R. Saito et al. / Journal of Photochemistry and Photobiology A: Chemistry 293 (2014) 12–25
15
preparative thin-layered chromatography on Merck silica gel (par-
ticle size, 5–40 m; 200 × 200 × 1.75 mm, 5 plates) with a mixed
solvent system (ethylacetate:hexane = 8:3) as a mobile phase to
give 9a (293 mg, 77%) in the form of a pale yellow solid and 10a
(17 mg, 4%) in the form of a pale yellow solid. 9a: mp152–154 ◦C
(ethanol–hexane); ıH (400 MHz, CDCl3) 4.78 (br. s, 2H), 7.77 (d,
J = 8.3, 2H), 7.88 (d, J = 8.3, 2H), 8.13 (s, 1H); ꢂmax (KBr)/cm−1 3415,
3311, 3185, 1642, 1616, 1449, 1406, 1320, 852; m/z (positive-EI)
(relative intensity) 319 (93), 317 (M+, 100), 211 (61), 184 (47).
Anal. Calcd for C11H7BrF3N3: C, 41.53; H, 2.22; N, 13.21. Found:
C, 41.94; H, 2.06; N, 12.89. 10a: mp 194–196 ◦C (ethanol–hexane);
ıH (400 MHz, CDCl3) 4.94 (br. s, 2H), 7.70 (d, J = 8.0, 2H), 7.80 (d,
J = 8.0, 2H), 7.96 (d, J = 8.0, 2H), 8.07 (d, J = 8.0, 2H), 8.55 (s, 1H); ꢂmax
(KBr)/cm−1 3482, 3288, 3152, 1630 (sh), 1618, 1536, 1464, 1425,
1408, 1329, 852; m/z (positive-EI) (relative intensity) 383 (100, M+),
382 (41), 356 (15), 314 (10). Anal. Calcd for C18H11F6N3: C, 56.40;
H, 2.89; N, 10.96. Found: C, 56.54; H, 2.72; N, 10.86.
a yellowish brown solid of 14. Yield: 1.16 g (88%); mp 133 ◦C (deco-
mop); ıH (270 MHz, CDCl3) 5.06 (br. s, 2H), 7.34–7.48 (m, 3H),
7.84–7.89 (m, 2H), 8.41 (s, 1H); m/z (positive-EI) (relative intensity)
251 (91, [M + 2]+), 249 (100, M+), 170 (17), 143 (20), 116 (62).
2.8.6. 2-Amino-5-phenyl-3-(4-trifluoromethylphenyl)pyrazine
(11a)
Method
A (from 9a): In this method 11a was prepared
from 7 (137 mg, 4.30 × 10−4 mol) with tetrakis(triphenylphos-
phine)palladium (25 mg, 2.1 × 10−5 mol), 4-trifluoromethyl-
phenylboronic acid 8a (57.3 mg, 4.70 × 10−4 mol), and 0.5 ml
of 2-mol dm−3 sodium carbonate using a method similar to
that for preparing 9a. Yield: 111 mg (82%). Method B (from
14): 11a was prepared from 14 (251 mg, 1.00 mmol) with
tetrakis(triphenylphosphine)palladium (43 mg, 3.7 × 10−5 mol),
4-trifluoromethylphenylboronic acid 8a (285 mg, 1.5 mmol), and
0.9 ml of 2-mol dm−3 sodium carbonate i using a method similar
to that for preparing 9a, except refluxing for 9 h. The product
was isolated by column chromatography on silica gel (particle
size, 63–200 m; 100 g) with a mixed solvent system (ethylac-
etate:chloroform = 4:1) as eluents. Yield: 301 mg (95%). Compound
11a was obtained as tan needles (from ethanol); mp 190–190 ◦C;
ıH (270 MHz, CDCl3) 4.78 (br. s, 2H), 7.35–7.49 (m, 3H), 7.79 (d,
J = 8.6, 2H), 7.95–8.00 (m, 4H), 8.51 (s, 1H); ꢂmax (KBr)/cm−1 3405,
3305, 3172, 1641, 1614, 1530, 1465, 1406, 1322, 849, 762, 695;
m/z (positive-EI) (relative intensity) 315 (100, M+), 288 (23), 102
(68). HRMS (positive-EI) Calcd for C17H12F3N3: 315.0983. Found:
315.1038.
2.8.2. 2-Amino-5-bromo-3-(4-methoxyphenyl)pyrazine (9c)
Prepared from 7 (304 mg, 1.20 mmol) with tetrakis(triphenyl-
phosphine)palladium (112 mg, 9.6 × 10−5 mol, 8 mol%), 4-
methoxyphenylboronic acid 8c (182 mg,1.20 mmol), and 1.5 ml
of 2-mol dm−3 sodium carbonate using a method similar to
that for preparing 9a: yield, 171 mg (51%); mp 143–145 ◦C
(ethanol–hexane); ıH (400 MHz, CDCl3) 3.87 (s, 3H), 4.76 (br. s,
2H), 7.01 (d, J = 9.0, 2H), 7.69 (d, J = 9.0, 2H), 8.03 (s, 1H); ꢂmax
(KBr)/cm−1 3470, 3292, 3146, 2827, 1631, 1609, 1508, 1440, 1391,
1251, 839. Anal. Calcd for C11H10BrN3O: C, 47.16; H, 3.60; N, 15.00.
Found: C, 47.28; H, 3.46; N, 14.85.
2.8.7. 2-Amino-3,5-diphenylpyrazine (11b)
This compound was obtained as a by-product in the synthesis of
5c: yield, 44 mg (12%). Identification of the product was achieved
by comparing its spectral features with that of previously reported
data [31].
Prepared from
7
(401 mg, 1.59 mmol) with tetrakis
(triphenylphosphine)palladium (72 mg, 6.2 × 10−5 mol), phenyl-
boronic acid 8b (491 mg, 4.03 mmol), and 8.0 ml of 2-mol dm−3
sodium carbonate using a method similar to that for preparing
9a, except refluxing for 5 h in 1,2-dimethoxyehane. The product
was isolate by column chromatography on silica gel (particle
size, 63–200 m; 70 g), eluted with a mixed solvent system
(first ethylacetate:chloroform:hexane = 1:1:1, and then ethylac-
etate:chloroform = 1:1) to give 11b as pale yellow solids. Yield:
360 mg (91%); mp 134–135 ◦C; ıH (270 MHz, CDCl3) 4.84 (br. s, 2H),
7.32–7.56 (m, 6H), 7.80–7.84 (m, 2H), 7.95–7.99 (m, 2H), 8.45 (s,
1H); ꢂmax (KBr)/cm−1 3461, 3282, 3144, 1625, 1536, 1459, 1436,
746, 688; m/z (positive-EI) (relative intensity) 247 (100, M+), 220
(17), 116 (12), 102 (22), 89 (10). HRMS (positive-EI) Calcd for
2.8.4. 2-Amino-5-phenylpyrazine (13)
Prepared from 12 (122 mg, 7.01 × 10−4 mol) with tetrakis
(triphenylphosphine)palladium
(33.5 mg,
2.90 × 10−5 mol),
phenylboronic acid 8b (116 mg, 9.53 × 10−4 mol), and 1.0 ml
of 2-mol dm−3 sodium carbonate using a method similar to that
for preparing 9a, except refluxing for 12 h. The product was
isolate by column chromatography on silica gel (particle size,
63–200 m; 30 g), eluting with a mixed solvent system (ethy-
lacetate:chloroform = 1:1), followed by recrystallization from
ethanol–hexane to give 13 as tan needles: yield, 89.2 mg (74%);
mp: 146–147 ◦C; ıH (400 MHz, CDCl3) 4.61 (br. s, 2H), 7.35–7.49
(m, 3H), 7.87–7.90 (m, 2H), 8.80 (d, J = 1.4, 1H), 8.46 (d, J = 1.4, 1H);
ꢂmax (KBr)/cm−1 3340, 3174, 3020, 1653, 1588, 1536, 1480, 1389,
751, 694 (␥CH). Anal. Calcd for C10H9N3: C, 70.16; H, 5.30; N, 24.54.
Found: C, 70.32; H, 5.19; N, 24.63.
C16H13N3: 247.1108. Found: 247.1085.
2.8.8. 2-Amino-5-phenyl-3-(4-methoxyphenyl)pyrazine (11c)
Method
A
(from 9c): In this method 11c was prepared
from 9c (114 mg, 4.07 × 10−4 mol) with tetrakis(triphenyl-
phosphine)palladium (25 mg, 2.1 × 10−5 mol), 4-methoxyphenyl-
boronic acid 8c (57 mg, 4.7 × 10−4 mol), and 0.5 ml of 2-mol dm−3
sodium carbonate in using a method similar to that for prepar-
2.8.5. 2-Amino-3-bromo-5-phenylpyrazine (14)
ing 9a. Yield: 109 mg (96%). Method B (from 14): In this
To a solution of aminopyrazine 13 (902 mg, 5.27 mmol) in chlo-
roform (40 ml) was added tetrabutylammonium tribromide (3.11 g,
6.44 mmol) and pyridine (7.0 ml) under argon atmosphere, and
the mixture was then stirred for 3 h with heating on an oil bath
(55–58 ◦C) under argon. After cooling to room temperature water
was added to the reaction mixture, and then the mixture was
stirred for another 20 min at room temperature. Organic materials
were then extracted with chloroform (50 ml × 3), and the combined
organic layer was dried over sodium carbonate. The removal of the
solvent afforded black mass, which was purified by column chro-
matography on silica gel (particle size, 63–200 m; 530 g), eluting
with a mixed solvent system (ethylacetate:chloroform = 1:1) to give
method 11c was prepared from 14 (50 mg, 0.2 mmol) with
tetrakis(triphenylphosphine)palladium (21 mg, 1.8 × 10−5 mol),
4-methyoxhyphenylboronic acid 8c (40 mg, 0.26 mmol), and 0.3 ml
of 2-mol dm−3 sodium carbonate using a method similar to that
for preparing 9a, except refluxing for 13 h in 1,2-dimethoxyethane.
Yield: 52 mg (94%). Compound 11c was obtained as tan needles
(from ethanol); mp 138–139 ◦C; ıH (270 MHz, CDCl3) 4.78 (br. s,
2H), 7.05 (d, J = 8.9, 2H), 7.32–7.47 (m, 3H), 7.79 (d, J = 8.9, 2H),
7.94–7.99 (m, 4H), 8.42 (s, 1H); ꢂmax (KBr)/cm−1 3449, 3305,
3170, 1636, 1608, 1533, 1510, 1461, 1245, 839, 766, 695; m/z
(positive-EI) (relative intensity) 277 (100, M+). HRMS (positive-EI)
Calcd for C17H15N3O: 277.1215. Found: 277.1188.